Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2018International Journal of CancerOpen Access

Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

TITakeshi IshikawaHokkaido University of ScienceTOTetsuya OkayamaKyoto Prefectural University of MedicineNSNaoyuki SakamotoAsahi University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ishikawa et al. (2018) studied this question.

synapsesocial.com/papers/6a767d0846f688d752c44895https://doi.org/10.1002/ijc.31285
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Adaptive immune responses mediated by natural killer cells2010 · 154 citations
  2. 2Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer2008 · 1,650 citations
  3. 3Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)2014 · 141 citations
  4. 4Pilot Study of the Mechanism of Action of Preoperative Trastuzumab in Patients with Primary Operable Breast Tumors Overexpressing HER22004 · 516 citations
  5. 5Age, Thymopoiesis, and CD4+ T-Lymphocyte Regeneration after Intensive Chemotherapy1995 · 1,061 citations